Home Navidea Biopharmaceuticals Downgraded by Zacks to "Sell"
 

Keywords :   


Navidea Biopharmaceuticals Downgraded by Zacks to "Sell"

2015-10-11 15:25:58| Biotech - Topix.net

According to Zacks, "Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek , AZD4694 and RIGScan .

Tags: sell downgraded zacks biopharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11
24.113DSLL
24.11
24.11
24.11
24.11logicool flight switch panel
24.11Z
24.11 126
More »